H ypertrophic cardiomyopathy (HCM) is an inherited myocardial disorder characterized by increased left ventricular wall thickness, which is not solely explained by abnormal loading conditions. 1 The clinical perception is that the more severe the hypertrophy, the higher is the risk of sudden cardiac death (SCD) 2 and left ventricular maximal wall thickness (MWT) is one of several clinical features used to guide prophylactic implantable cardioverter defibrillator (ICD) therapy. [1][2][3] However, patients at the most severe end of the hypertrophy spectrum are under-represented in clinical studies 4,5 and their assumed highrisk status is based on extrapolation of data from other patient subgroups. A recent multicenter study reported that patients with left MWT ≥35 mm were not at higher risk of SCD compared with patients with lesser hypertrophy, 6 echoing the findings of an earlier cohort study. 7 The aim of this study was to examine the relation between MWT and the risk of SCD.
Methods Study Design and OverviewThis is a retrospective, multicenter, longitudinal cohort study conducted by the Hypertrophic Cardiomyopathy Outcomes Investigators (http://www.HCMRisk.org). The relation of SCD risk and MWT was © 2016 American Heart Association, Inc.